Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_assertion type Assertion NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_head.
- NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_assertion description "[These results suggest that CD123 CAR T cells are a promising immunotherapy for the treatment of high-risk AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_provenance.
- NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_assertion evidence source_evidence_literature NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_provenance.
- NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_assertion SIO_000772 24030378 NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_provenance.
- NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_assertion wasDerivedFrom befree-2016 NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_provenance.
- NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_assertion wasGeneratedBy ECO_0000203 NP1109992.RAfEt7EbxCxQCWrFxERQ0_dwfWp0Ew4fJXdeFovsU9b_c130_provenance.